Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer

Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer

<p>Representativeness of Study Participants</p>

Gardado en:
Detalles Bibliográficos
Autor Principal: Aurelius Omlin (14971513) (author)
Outros autores: Richard Cathomas (14971516) (author), Gunhild von Amsberg (14971519) (author), Christoph Reuter (14971522) (author), Susan Feyerabend (14971525) (author), Wolfgang Loidl (14971528) (author), Martin Boegemann (14971531) (author), Anja Lorch (14971534) (author), Axel Heidenreich (14971537) (author), Igor Tsaur (14971540) (author), Julian Larcher-Senn (14971543) (author), Stefan A.J. Buck (14971546) (author), Ron H.J. Mathijssen (14971549) (author), Ulrich Jaehde (14971552) (author), Silke Gillessen (14971555) (author), Markus Joerger (14971558) (author)
Publicado: 2025
Subjects:
Cancer
Therapeutic Research and Development
Clinical Research and Trials
Methods and Technology
Chemotherapy
Clinical-Stage Research
Computational Methods
Algorithms
Genitourinary Cancers
Prostate cancer
Pharmacology
Pharmacokinetics and pharmacodynamics
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
Descripción
Summary:<p>Representativeness of Study Participants</p>

Títulos similares